Smith & Nephew plc (SN) PT Lowered to GBX 1,275 at Berenberg Bank

Smith & Nephew plc (LON:SN) had its price target trimmed by Berenberg Bank from GBX 1,340 ($16.75) to GBX 1,275 ($15.93) in a report released on Wednesday morning. The brokerage currently has a hold rating on the stock.

SN has been the subject of several other research reports. Morgan Stanley reaffirmed an overweight rating on shares of Smith & Nephew plc in a research note on Wednesday, January 11th. Goldman Sachs Group, Inc. (The) decreased their price target on Smith & Nephew plc from GBX 1,370 ($17.12) to GBX 1,310 ($16.37) and set a buy rating for the company in a research report on Friday, November 25th. Deutsche Bank AG reiterated a hold rating on shares of Smith & Nephew plc in a research report on Wednesday, October 26th. J P Morgan Chase & Co reiterated a neutral rating and issued a GBX 1,260 ($15.75) price target on shares of Smith & Nephew plc in a research report on Thursday, January 12th. Finally, Jefferies Group LLC decreased their price target on Smith & Nephew plc from GBX 1,395 ($17.43) to GBX 1,370 ($17.12) and set a buy rating for the company in a research report on Wednesday, December 7th. Nine equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company has an average rating of Hold and a consensus price target of GBX 1,292.08 ($16.15).

Smith & Nephew plc (LON:SN) opened at 1194.00 on Wednesday. Smith & Nephew plc has a 1-year low of GBX 1,052.00 and a 1-year high of GBX 1,324.00. The stock’s 50 day moving average is GBX 1,206.11 and its 200-day moving average is GBX 1,203.59. The firm’s market cap is GBX 10.58 billion.

This story was first published by sleekmoney and is the sole property of of sleekmoney. If you are accessing this story on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this story can be accessed at http://sleekmoney.com/smith-nephew-plc-sn-pt-lowered-to-gbx-1275-at-berenberg-bank/1661997.html.

About Smith & Nephew plc

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives.

This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/smith-nephew-plc-sn-pt-lowered-to-gbx-1275-at-berenberg-bank/1661997.html

Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.

 

Leave a Reply

Your email address will not be published. Required fields are marked *